COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery

Prev Med. 2021 Oct:151:106687. doi: 10.1016/j.ypmed.2021.106687. Epub 2021 Jun 30.

Authors

Linda Rabeneck¹, Mona Saraiya²

Affiliations

¹ Dalla Lana School of Public Health and Department of Medicine, University of Toronto, and Cancer Care Ontario, Toronto, Canada. Electronic address: Linda.Rabeneck@ontariohealth.ca.
² Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Early Detection of Cancer
Humans
Neoplasms* / diagnosis
SARS-CoV-2